Biomarkers for the effects of benzodiazepines in healthy volunteers

Studies of novel centrally acting drugs in healthy volunteers are traditionally concerned with kinetics and tolerability, but useful information may also be obtained from biomarkers of clinical endpoints. A useful biomarker should meet the following requirements: a consistent response across studies...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: de Visser, S J, van der Post, J P, de Waal, P P, Cornet, F, Cohen, A F, van Gerven, J M A
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Science Inc 2003
Soggetti:
Pharmacodynamics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884188/
https://ncbi.nlm.nih.gov/pubmed/12534639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2002.t01-10-01714.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi